These studies have demonstrated that the leukemia proto-oncoprotein Evi1 formed a bridge between the epigenetic machinery and signaling pathways and proposed therapeutic targets for the eradication of Evi1-related myeloid malignancies. The gene discussed is MECOM; the disease is leukemia.